C12N 2760/16021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/16021 (Viruses as such) appears on 25 US grants and 39 published applications in this corpus.
Search patents in C12N- Granted patents
- 25
- Published applications
- 39
- Assignees
- 30
- Inventors
- 88
- Latest grant
- 18 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 2 |
| 2013 | 0 | 1 |
| 2014 | 4 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 4 |
| 2017 | 4 | 2 |
| 2018 | 2 | 3 |
| 2019 | 2 | 2 |
| 2020 | 2 | 2 |
| 2021 | 1 | 3 |
| 2022 | 1 | 1 |
| 2023 | 3 | 2 |
| 2024 | 0 | 3 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Recombinant influenza viruses with stabilized HA for replication in eggs18 Mar 2025US 12,251,436 B2The University of Tokyo
- Barcoded influenza viruses and deep mutational scanning libraries including the same21 Nov 2023US 11,821,111 B2Fred Hutchinson Cancer Center
- Recombinant influenza viruses with stabilized HA for replication in eggs7 Nov 2023US 11,807,872 B2The University of Tokyo
- Reassortant influenza virus production method25 Apr 2023US 11,633,469 B2The Research Foundation for Microbial Diseases of Osaka University
- Mutant virus, preparation method therefor and application thereof29 Nov 2022US 11,510,974 B2Peking University
- Recombinant influenza viruses with stabilized ha for replication in eggs14 Aug 2025US 2025/0255953 A1The University of Tokyo
- A vaccine for coronavirus and influenza virus, and method for preparation thereof5 Dec 2024US 2024/0398930 A1Bharat Biotech International Limited
- Recombinant influenza viruses with stabilized ha for replication in eggs7 Mar 2024US 2024/0076632 A1The University of Tokyo
- Barcoded influenza viruses and deep mutational scanning libraries including the same8 Feb 2024US 2024/0044048 A1Fred Hutchinson Cancer Center
- Nucleic acid construct, recombinant influenza virus, method for preparing a recombinant influenza virus, composition and use19 Oct 2023US 2023/0332174 A1FundaçãO Oswaldo Cruz
Most cited
By later US patents
- Influenza M2 protein mutant viruses as live influenza attenuated vaccines34US 9,474,798 B2Wisconsin Alumni Research Foundation · 2016
- Influenza M2 protein mutant viruses as live influenza attenuated vaccines18US 10,119,124 B2Wisconsin Alumni Research Foundation (WARF) · 2018
- Recombinant influenza viruses with stabilized HA for replication in eggs13US 11,197,926 B2The University of Tokyo · 2021
- Recombinant influenza viruses with stabilized HA for replication in eggs10US 11,807,872 B2The University of Tokyo · 2023
- Production of viruses viral isolates and vaccines10US 7,504,248 B2Crucell Holland B. V. · 2009